PACAP potentiates L-type calcium channel conductance in suprachiasmatic nucleus neurons by activating the MAPK pathway. J Neurophysiol 88: 1374 -1386, 2002; 10.1152/jn.00896.2001. The endogenous pacemaker activity of the suprachiasmatic nuclei (SCN; the master clock in mammals) is regulated by photic information relayed from the retina to the SCN via the retinohypothalamic tract (RHT). Recent work has revealed that glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) are stored in RHT nerve terminals and function in a coordinated manner to regulate clock timing. To address this interaction on a cellular level, Fura-2 Ca 2ϩ digital imaging was employed and the effects of PACAP on glutamate evoked Ca 2ϩ transients in SCN neurons were examined. Pretreatment of SCN neurons with PACAP markedly potentiated Ca 2ϩ transients elicited by both exogenous glutamate application and synaptically released glutamate. Many neurons became responsive to glutamate only after PACAP administration, suggesting that PACAP sets the lower concentration threshold required for glutamate to initiate a robust rise in postsynaptic cytosolic Ca 2ϩ . Facilitation of glutamate-induced Ca 2ϩ transients was inhibited by nimodipine, indicating that PACAP potentiates L-type Ca 2ϩ channel activity. The modulatory actions of PACAP were inhibited by antagonizing signaling via the p42/44 mitogen-activated protein kinase (MAPK) signal transduction cascade. Immunocytochemistry and Western analysis confirmed that PACAP stimulates MAPK activity at doses and time points shown to potentiate Ca 2ϩ influx. Down-regulation of protein kinase C (PKC) with the phorbol ester 12-O-tetradecanoyl phorbol 13-acetate (TPA) or PKC inhibition with bisindolylmaleimide attenuated the actions of PACAP, indicating that PKC also couples PACAP to potentiation of depolarization-induced Ca 2ϩ transients. The data presented here identify potentially important mechanisms by which PACAP regulates SCN physiology.
I N T R O D U C T I O N
As the master circadian clock in mammals, the suprachiasmatic nuclei (SCN) of the hypothalamus drive a complex array of biochemical, physiological, and behavioral rhythms (reviewed by Miller et al. 1996; Moore 1997) . The endogenous pacemaker activity of the SCN is regulated by a variety of stimuli, light being the most potent. Photic information is relayed from the eyes to the SCN via the retinohypothalamic tract (RHT). A number of studies have shown that lightinduced secretion of glutamate from RHT nerve terminals is an essential event that links photic input to entrainment of the circadian clock. For example, infusion of ionotropic glutamate receptor antagonists into the region of the SCN blocks lightinduced phase-shifts (Colwell and Menaker 1992; Colwell et al. 1991) .
In addition to glutamate, the RHT also secretes modulatory peptides. One of these peptides, pituitary adenylate cyclase activating polypeptide (PACAP), has been shown to be a potent regulator of the circadian clock (reviewed by Hannibal et al. 1998) . PACAP is a member of the glucagon/vasoactive intestinal peptide/secretin/growth hormone-releasing hormone family of structurally related peptides. Two forms of PACAP are found within the brain, a 38 amino acid residue form and a 27 residue peptide formed from internal cleavage of PACAP 38 (Miyata et al. 1989 (Miyata et al. , 1990 . PACAP 38 is the predominant form, comprising Ͼ90% of the PACAP isoform content in the brain (Arimura et al. 1991; Ghatei et al. 1993; Hannibal et al. 1995) . Through two classes of G protein-coupled receptors, PACAP couples to the activation of signaling pathways that result in cAMP synthesis, and activation of phospholipase C, thus leading to inositol 1,4,5 tris-phosphate (IP3) production, protein kinase C (PKC) activation, and release of Ca 2ϩ from intracellular stores (Tanaka et al. 1996 (Tanaka et al. , 1997 . Interestingly, PACAP has also been shown to stimulate activation of the p42/44 mitogen-activated protein kinase (MAPK) cascade in PC12 cells (Barrie et al. 1997 ), a neuron-like model cell line.
Recently, several studies have shown that PACAP alters the ability of glutamate to phase shift SCN firing patterns in slice (Chen et al. 1999; Harrington et al. 1999) . It is of interest that immunohistochemical examination has colocalized expression of glutamate with PACAP in retinal ganglion nerve terminals that innervate the SCN (Hannibal et al. 2000) , thus raising the possibility that PACAP and glutamate are co-released and function in a coordinated manner to regulate SCN timing.
To gain insight into the functional role of PACAP in the SCN, we examined the interactions between glutamate and PACAP at the level of Ca 2ϩ metabolism. Modulation of Ca 2ϩ was examined because of the proposed role glutamate-induced increases in cytosolic Ca 2ϩ play in initiating the series of transcriptional events that give rise to light-dependent entrainment of the circadian clock. Results obtained in this study reveal that PACAP significantly augments the ability of glutamate to elicit increases in cytosolic Ca 2ϩ levels via a mecha-nism requiring activation of the MAPK cascade. Portions of this work have been published in abstract form (Obrietan 2000) .
M E T H O D S
Tissue culture SCN neurons were cultured from embryonic day 18 to postnatal day 1 Sprague-Dawley rat pups. Initially, pups were decapitated, and their brains were rapidly removed and placed in dissociation media [DM; (in mM) 90 Na 2 SO 4 , 30 K 2 SO 4 , 16 MgCl 2 , 0.25 CaCl 2 , 32 HEPES, and 0.01% phenol red (Sigma), pH 7.7]. Two techniques were used for isolation of the SCN. In our first technique, brains were cut into 500-m coronal sections with a tissue chopper, the SCNcontaining slice was identified using anatomical markers, and the SCN was excised from the slice with the use of micro-dissection scissors and a dissecting microscope. The tissue excised using this technique was used to analyze PACAP modulation of exogenously evoked Ca 2ϩ transients. For the second technique, an ϳ1-mm cube of tissue containing the SCN and the surrounding hypothalamic tissue was excised from the ventral surface of the brain. The medial optic chiasm was used as a reference point for the excision. Tissue (SCN and non-SCN hypothalamic tissue) isolated using this co-culturing technique was used to analyze the modulatory effects of PACAP on Ca 2ϩ transients initiated by synaptic glutamate release, and for Western and immunocytochemical analysis. Tissue was then washed three times in DM, finely minced with a razor blade, and digested with a mild protease solution (100 units/ml papain latex, Worthington; 4.5 mg cysteine, Sigma; in DM) at 37°C for 30 min. After removal from the digestion solution, the tissue was washed three times in DM and transferred to standard tissue culture medium [minimal essential medium (MEM); Gibco] containing 5% fetal bovine serum, 100 units/ml penicillin/ streptomycin, and 6 g/l glucose. The tissue was then triturated into a single cell suspension using a 5-ml serological pipette and plated on either 22-mm 2 glass coverslips coated with high molecular weight (Ͼ540 kD; Sigma) poly-D-lysine or poly-D-lysine-coated 12-well dishes. The media was changed 2 h after plating the cells. Cultures were maintained at 37°C and 5% CO 2 in a Napco 6100 incubator. After 1 day in vitro, cytosine arabinofuranoside (8 M) was added to the tissue culture medium to slow glial cell proliferation. Experiments were performed after 12-15 days in vitro. Neurons were cultured at a density of 50,000/cm 2 for all experiments.
To verify that relevant physiological responses could be recorded from SCN neurons using the co-culturing technique described above, tissue from the SCN and the surrounding hypothalamic region were isolated separately, and the non-SCN tissue was irreversibly labeled with a fluorescent chloromethyl derivative tag (CellTracker Green, 25 M; Molecular Probes) using the protocol provided by the manufacturer. This thiol-reactive probe freely diffuses into cells and forms membrane-impermeable glutathione-fluorescent dye adducts. Importantly, the label is retained for many weeks, does not appear to alter the health or physiological properties of the cells, and is not transferred from cell to cell. After labeling, cells from the two brain regions were combined and co-cultured. The fluorescent tag was used to identify the two populations of neurons on the day of imaging.
Calcium digital imaging
Initially, cells were incubated in HEPES perfusion solution (in mM: 137 NaCl, 25 glucose, 10 HEPES, 5 KCl, 1 MgCl 2 , and 3 CaCl 2 , pH 7.4) containing 5 M fura-2 acetoxymethylester for 30 min at 37°C. To facilitate N-methyl-D-aspartate (NMDA) receptor activity during assays of synaptic glutamate release, 2 M glycine was added and Mg 2ϩ was removed from the standard HEPES perfusion solution. Coverslips were washed two times and placed in a laminar flow multiport perfusion chamber (Forscher et al. 1987) , and cells were imaged on an inverted microscope (Leica DMIRB) with a 40ϫ objective with high UV light transmittance. Fluorescent signal was excited at 340 and 380 nm and captured using a 16-bit digital camera (Princeton Instruments). Switching of the excitation signal was achieved using a Sutter filter wheel controlled by a lambda 10 processor (Sutter Instruments). Ratiometric single cell imaging data were collected with Fluor software (Universal Imaging) running on a PC. Data acquisition was performed every 5 s. Ratiometric fluorescent values were converted to free Ca 2ϩ values with the equation
where R is the ratio of the two fluorescence intensities, R min is the ratio in the absence of Ca 2ϩ , and R max is the ratio in a saturating concentration of Ca 2ϩ , as described by Grynkiewicz et al. (1985) .
Ca 2ϩ imaging: analysis
Calibrated cytosolic Ca 2ϩ data from single neurons were analyzed with Igor Pro software (WaveMetrics) as described previously (Obrietan and van den Pol 1995; . For assays that measure the effects of PACAP on Ca 2ϩ transients initiated by synaptic glutamate release, the mean Ca 2ϩ level in the presence of glutamate receptor antagonists was subtracted from the mean Ca 2ϩ rise initiated by antagonist withdrawal. Data were analyzed over a 30-s period, 120 s after withdrawal of glutamate receptor antagonists. Data are presented as mean Ca 2ϩ rise Ϯ SE. To assess the effects of PACAP on exogenously-induced Ca 2ϩ transients, the mean baseline (unstimulated) Ca 2ϩ level over a 20-s period prior to stimulation was subtracted from the maximal evoked Ca 2ϩ rise. Data are presented as the peak Ca 2ϩ rise Ϯ SE.
Immunocytochemistry
Cells were stimulated for 5 min and rapidly fixed in ice-cold 90% methanol and 10% acetic acid for 5 min. Cells were then washed three times in phosphate-buffered saline (PBS), and then blocked with 1% normal goat serum and 10% bovine serum albumin (BSA) in PBS with 0.1% Triton X-100 (PBST) and 0.02% azide for 2 h at room temperature. Next, the tissue was incubated overnight at 4°C with an affinity-purified rabbit polyclonal antibody raised against the activated (i.e., phosphorylated at Thr-202 and Tyr-204) forms of erk-1 and erk-2 (1:500 final dilution, NEB). Cells were then washed six times (5 min per wash with PBST) and incubated (4 h at room temperature) with a fluorescein-conjugated secondary antibody (4 g/l final dilution, Jackson Immunochemicals) raised against rabbit IgG. The cells were then washed six times and incubated (3 h at room temperature) with an Alexa-488-conjugated anti-fluorescein antibody raised in rabbit (2 g/ml final dilution, Molecular Probes). After washing, the cells were mounted using gel mount (Biomedia Inc.) and visualized using an MRC-600 scanning laser confocal microscope.
Western blotting
Cultured cells were stimulated for 5 min and then lysed in 100 l of hot 6ϫ sample buffer. Lysates were heated to 90°C for 10 min, vortexed for 15 s, and followed by centrifugation for 7 min at 15,000 g. Extract (30 l/lane) was loaded onto a 10% SDS-PAGE gel and electrophoresed using standard procedures. Protein was transblotted onto polyvinylidene fluoride (PVDF) (Immobilon P; Millipore). Following blocking with 10% (wt/vol) powdered milk dissolved in PBST, membranes were incubated (4°C overnight) in PBST with a mouse monoclonal antibody against the activated forms of erk-1 and erk-2 (1:5,000 final dilution; Sigma). Membranes were treated with a rabbit anti-mouse IgG alkaline phosphatase-conjugated secondary antibody (1:2,000; NEN) and immunoreactivity was developed using the Western-CDP star alkaline phosphatase chemiluminescent detection system (NEN). Membranes were then probed overnight with a goat polyclonal antibody against total erk-1 and erk-2 (1 g/l final dilution, Santa Cruz Biochemicals) followed by a donkey anti-goat IgG antibody conjugated to horseradish peroxidase. The signal was visualized using Renaissance chemiluminescent HRP substrate (NEN). Between each antibody treatment, membranes were washed a minimum of six times (5 min per wash) in PBST with 5% milk. Quantitation of band intensity was performed using Scion Image analysis software. Band intensity for phosphorylated erk-2 was normalized to total erk-1 for the corresponding lane. Each experiment was repeated a minimum of three times. cAMP assay cAMP levels were measured by determining the ratio of cAMP to a total ATP, ADP, and AMP pool as described by Wong et al. (1991) . Briefly, cells were incubated in standard tissue culture media containing 4 Ci/ml [3H]adenine (ICN) for 8 h. Cells were stimulated with media containing PACAP and 3-isobutyl-1-methylxanthine (IBMX, 1 mM; Sigma). Control cells were mock stimulated and treated with IBMX. After 5 min, media was aspirated, and the reaction was terminated by administration of 5% trichloroacetic acid supplemented with 1 M cAMP. An analogous procedure was used to examine forskolin (Sigma)-mediated increases in cAMP accumulation. Dowex AG 50WX4 and neutral alumina chromatography were used to isolate soluble nucleotides. A scintillation counter was used to measure the ratio of [3H]ATP, [3H]ADP, and [3H]AMP to [3H]cAMP. Experiments were performed in triplicate. ovine, rat) was acquired from Bachem. NMDA, glutamate, nimodipine, bicuculline, TTX, PMA, forskolin, 6,7-dinitroquinoxaline-2,3-dione (DNQX), and 2-amino-5-phosphonopentanoic acid (AP5) were acquired from Sigma-RBI. Bisindolylmaleimide, Gö 6976, U0126, and PD 98059 were acquired from Calbiochem. Rp-cAMPs was acquired from LC laboratories.
Materials

R E S U L T S
Given that PACAP is a known neuromodulator, we were interested in examining the physiological ramifications of coordinated activation of peptidergic and glutamatergic signaling. To assess potential interactions, we examined the ability of PACAP to modulate Ca 2ϩ transients initiated by exogenous glutamate application.
In an initial set of experiments, the capacity of PACAP to elicit a rise in cytosolic Ca 2ϩ levels in SCN neurons was examined. Perfusion of 200 nM PACAP triggered Ca 2ϩ transients in approximately 45% of all neurons examined (n ϭ 157; Fig. 1A ). Often, the Ca 2ϩ rise initiated by PACAP consisted of rapid and sharp transients that persisted for several minutes after withdrawal of PACAP from the perfusion solution. These data are suggestive of Ca 2ϩ release from internal stores, as has been previously reported by Kopp et al. (1999) for SCN neurons. Lower doses of PACAP (0.1-1.0 nM) triggered Ca 2ϩ transients in Ͻ1% of neurons (n ϭ 157). Next, we assessed the modulatory effects of PACAP on glutamate-evoked increases in cytosolic Ca 2ϩ . Toward this end, SCN neurons were repeatedly challenged with glutamate (3 M) both before and after PACAP (200 nM) administration. Before PACAP administration, glutamate triggered relatively low-amplitude Ca 2ϩ transients ( Fig. 1, B1-B4 and C). However, after 2 min of PACAP administration, there was a significant (P Ͻ 0.0001, 2-tailed Student's t-test) increase in the amplitude of glutamate-mediated Ca 2ϩ transients. Before PACAP administration, the mean Ca 2ϩ rise elicited by glutamate was 40 Ϯ 6 nM; after PACAP administration the mean Ca 2ϩ rise was 104 Ϯ 11 nM (n ϭ 34). Interestingly, some neurons were responsive to glutamate only after PACAP administration (Fig. 1, B2 and B3) .
Potentiation of glutamate-evoked Ca 2ϩ transients was independent of whether PACAP elicited a Ca 2ϩ response. Along these lines, potentiation was observed both in neurons that exhibited a Ca 2ϩ response to PACAP (Fig. 1, B3 and B4) and in neurons where no change in basal Ca 2ϩ was observed (Fig.  1, B1 and B2) . NMDA was added at the end of many experiments to verify that the recorded cells were neurons. In these experiments and other experiments where exogenous agents were applied to evoke Ca 2ϩ responses, tetrodotoxin (TTX; 500 nM) was added to all perfusion buffers to inhibit the potentially complicating effects of action potential-mediated transmitter release.
Glutamate-induced Ca 2ϩ transients are mediated in part by membrane depolarization-dependent opening of voltage-activated Ca 2ϩ channels (VACC). To assess whether PACAPinduced potentiation of glutamate responses is due to modulation of VACC activity, SCN neurons were repeatedly challenged with bath applications of K ϩ (15 mM). K ϩ -induced membrane depolarization triggered rapid and reproducible Ca 2ϩ transients ( Fig. 2A ). As was observed with glutamate, PACAP (200 nM) administration significantly (P Ͻ 0.0001, 2-tailed Student's t-test) potentiated K ϩ -evoked Ca 2ϩ transients (Fig. 2, A and D) . The potentiating actions of PACAP were dose-dependent; at 200 nM, PACAP elicited a Ն20% potentiation of K ϩ -evoked Ca 2ϩ transients in 55% of neurons, whereas at 2 nM, 7% of neurons exhibited reproducible potentiation of Ն20% (Fig. 2C ). Next, we assessed whether potentiation of VACC activity is the mechanism by which PACAP facilitates glutamate-induced Ca 2ϩ transients. Toward this end, cells were treated with the L-type VACC inhibitor nimodipine (5 M), and the capacity of PACAP to potentiate glutamateevoked Ca 2ϩ transients was assessed. Previous work on SCN neurons showed that the majority of VACC-induced Ca 2ϩ influx in cell bodies is mediated by L-type channels (Obrietan and van den Pol 1997) . Under this condition, K ϩ (15 mM) evoked a relatively modest 23 Ϯ 3 nM Ca 2ϩ rise (Fig. 2, B and D). In the absence of functional L-type VACCs, PACAP did not significantly (P Ͼ 0.05, 2-tailed Student's t-test) potentiate glutamate (3 M)-evoked Ca 2ϩ transients (Fig. 2, B and D) . Likewise, pretreatment of SCN cells with nimodipine blocked PACAP-mediated potentiation of depolarization-evoked Ca 2ϩ transients (Fig. 3 ). Collectively, these results reveal that PACAP-dependent potentiation of L-type VACC is an underlying mechanism that mediates facilitation of glutamateevoked Ca 2ϩ transients.
Potentiation of Ca 2ϩ transients mediated by spontaneous glutamate release
Next, the modulatory actions of PACAP on Ca 2ϩ transients mediated by synaptically released glutamate were assessed. To perform these experiments, SCN neurons were co-cultured with neurons from the surrounding hypothalamic areas, thereby providing glutamatergic synaptic inputs. As previously described , complex Ca 2ϩ transients are initiated by the removal of the ionotropic glutamate receptor antagonists AP5 (100 M) and DNQX (10 M) from the perfusion solution (Fig. 4 ). The ability of ionotropic glutamate receptor antagonists to suppress spontaneous Ca 2ϩ transients indicates that glutamate is secreted from the cultured cells. Similar results are observed with the addition and removal of TTX from the perfusion solution, indicating that action potentials stimulate glutamate release from synapticallycoupled neurons . Under conditions of spontaneous glutamate-mediated Ca 2ϩ transients, the administration of PACAP (200 nM) triggered a significant (P Ͻ 0.001, 2-tailed Student's t-test) increase in Ca 2ϩ levels (Fig. 4) . Initially, the withdrawal of AP5 and DNQX triggered a 67 Ϯ 5 nM Ca 2ϩ rise; PACAP increased the Ca 2ϩ rise to 95 Ϯ 5 nM, n ϭ 57. On reintroduction of glutamate receptor antagonists at the end of the experiment, cytosolic Ca 2ϩ returned to basal levels, indicating that PACAP was eliciting a modulatory action on the secretion and/or response to synaptically released glutamate. Interestingly, some neurons only exhibited robust Ca 2ϩ transients on PACAP administration (Fig. 4, bottom) , indicating that PACAP receptor activation is required for robust glutamate-mediated Ca 2ϩ transients.
To characterize further its modulatory actions, PACAP was applied in the presence of AP5 and DNQX and the residual effect on Ca 2ϩ transients mediated by synaptic glutamate release was assessed. Under this condition, a 90-s application of PACAP (200 nM) potentiated Ca 2ϩ transients triggered by subsequent withdrawals of AP5 and DNQX (Fig. 5A ). In ϳ35% of the cells examined, 200 nM PACAP initiated at least a twofold increase in the mean Ca 2ϩ rise (n ϭ 90). The modulatory actions of PACAP persisted for an extended period (Ͼ8 min) after it was washed from the perfusion chamber. Consistent with its effects on K ϩ -evoked Ca 2ϩ transients, the PACAP-induced facilitation was dose-dependent; robust potentiation was observed at 200 nM PACAP and little effect was observed at 1 nM PACAP (Fig. 5A ).
PACAP could facilitate responsiveness to synaptically released glutamate via a number of mechanisms, including the inhibition of GABAergic signaling. To address this possibility, the modulatory actions of PACAP were assessed while perfusing cells with the GABA A receptor antagonist bicuculline (20 M), thereby blocking the inhibitory actions of synaptically released GABA acting at the GABA A receptor. In most neurons ( Fig. 5B, top) (Kopp et al. 1999) . NMDA (30 M: arrow) was added at the end of the experiment to verify that the cells were neurons. B: neurons were repeatedly exposed to glutamate (arrowheads: 3 M, 10 s exposure duration). Before administration of PACAP (200 nM, 120 s exposure duration), glutamate-evoked Ca 2ϩ transients were relatively weak or absent. However, after bath application of PACAP, peak Ca 2ϩ transients stimulated by glutamate were markedly enhanced. To inhibit the complicating effects of action potential-mediated transmitter release, all bath solutions contained tetrodotoxin (TTX: 500 nM). Note that potentiation was independent of whether PACAP elicited a Ca 2ϩ rise. Horizontal bars below Ca 2ϩ traces in A and B denote time in minutes (min); vertical bars to the left of each trace denote the calibrated cytosolic Ca 2ϩ values. To gain an appreciation for the heterogeneity of response characteristics, traces from several neurons are shown for each experiment. C: graphical representations of mean glutamate-evoked Ca 2ϩ transients before and after PACAP administration. The filled bars represent the responses to the two consecutive glutamate-evoked Ca 2ϩ transients immediately before PACAP administration; the two open bars represent the two evoked Ca 2ϩ transients immediately after PACAP administration. Error bars denote SE. *: P Ͻ 0.0001, two-tailed Student's t-test. tiated glutamate-mediated Ca 2ϩ transients. This finding indicates that PACAP-mediated potentiation of glutamatergic neurotransmission does not result from modulation of GABA A receptor activity. Interestingly, some neurons (Fig. 5B, bottom) were responsive to withdrawal of glutamate receptor antagonists only after PACAP application.
To verify that SCN neurons exhibit PACAP-evoked potentiation of glutamatergic neurotransmission, we isolated neurons from the SCN and the surrounding hypothalamic region separately and irreversibly labeled the cells from surrounding hypothalamic region with a fluorescent chloromethyl derivative tag (CellTracker). The tissue was then co-cultured and the fluorescent tag was used to distinguish the two populations of neurons. Relative to fura-2 that labels all cells (Fig. 5C2 ), CellTracker was found in a subset of the cells (i.e., the non-SCN cells: Fig. 5C1 ). Using this criterion, SCN cells were specifically monitored for PACAP-induced potentiation of synaptically evoked Ca 2ϩ transients. Figure 5C3 shows the response characteristics of two SCN cells. In both cells, the administration of PACAP triggers a dramatic potentiation of Ca 2ϩ influx mediated by the synaptic release of glutamate. These data confirm that the potentiating actions of PACAP are observed in SCN cells.
Second messenger signaling events that couple PACAP to modulation of Ca 2ϩ transients
To begin to understand how PACAP potentiates Ca 2ϩ transients, we examined second messenger signaling pathways activated by PACAP. Because the modulatory actions of PACAP are independent of whether PACAP elicits a Ca 2ϩ rise, it is unlikely that signaling pathways activated by increased cytosolic Ca 2ϩ are involved [i.e., Ca 2ϩ /calmodulindependent protein kinases: (CaMKs)]. Initially, the contribution of cAMP-dependent signaling was examined. Toward this end, SCN neurons were incubated with 3 H-ATP for 6 h and stimulated with increasing concentrations of PACAP or the adenylyl cyclase activator forskolin to generate dose-response curves. After 5 min, cells were lysed and cAMP accumulation was measured. PACAP (Fig. 6A ) as well as forskolin (data not shown) stimulated robust increases in cAMP. To determine whether PACAP potentiates via a cAMP-dependent mechanism, data from the forskolin dose-response curve was used to determine the forskolin concentration that raised cAMP to a level equivalent to a concentration of PACAP (200 nM) that triggered robust potentiation. This forskolin concentration (150 nM: Fig. 6A ) was then assayed to determine whether elevated cAMP levels potentiate depolarization-induced Ca 2ϩ rises. Contrary to the effects of PACAP, forskolin did not potentiate the evoked Ca 2ϩ rise (Fig. 6, B and D) . Rather, increased cAMP tended to dampen the K ϩ -evoked Ca 2ϩ rise. In a second experiment to test the role of the cAMP/PKA signaling pathway, SCN neurons were incubated with the PKA inhibitor Rp-cAMPs (200 mM), and the effects of PACAP on evoked Ca 2ϩ responses were tested. Disruption of PKA-dependent signaling did not block PACAP-induced potentiation of depolarization-induced Ca 2ϩ rises (Fig. 6, C and D) . Together, these results indicate that PACAP does not potentiate depolarizationinduced Ca 2ϩ rises via a cAMP/PKA-dependent mechanism.
Next, we examined whether PKC-dependent signaling couples PACAP to facilitation of evoked Ca 2ϩ transients. For this study, PKC levels in cultured cells were down-regulated by pretreatment (24 h) with phorbol 12-O-tetradecanoylphorbol-13-acetate (PMA; 1 M). PKC down-regulation attenuated PACAP (200 nM)-induced potentiation of Ca 2ϩ transients stimulated by K ϩ (15 mM; Fig. 7, A and D) . Although attenuation was observed, PACAP still elicited a statistically significant potentiation of K ϩ -evoked Ca 2ϩ transients. The effects of two PKC inhibitors, bisindolylmaleimide (a broad range inhibitor) and Gö 6976 (inhibitor of Ca 2ϩ -dependent PKC isoforms), were also examined. Similar to the effect of 12-Otetradecanoylphorbol 13-acetate (TPA) down-regulation, bisindolylmaleimide reduced, but did not eliminate, PACAP-mediated potentiation of depolarization-induced Ca 2ϩ rises (Fig. 7,  B and D) . In the presence of bisindolylmaleimide, PACAP elicited a Ն20% potentiation of K ϩ -evoked Ca 2ϩ transients in 32% of neurons (n ϭ 88), whereas 55% of neurons exhibited PACAP potentiation of Ն20% under normal physiological FIG. 3. PACAP potentiates Ca 2ϩ transients via an L-type VACC-dependent mechanism. Cells were pretreated (10 min) and continuously perfused with the L-type Ca 2ϩ channel blocker nimodipine (5 M). Under this condition, potassium (K ϩ , arrowheads ϭ10 s exposure, 15 mM)-evoked Ca 2ϩ transients were largely inhibited. In the absence of functional L-type Ca 2ϩ channels PACAP (200 nM, bar ϭ120 s) did not significantly affect the magnitude of the depolarization-evoked Ca 2ϩ transient. conditions (Fig. 2C) . The inhibitor of Ca 2ϩ -dependent PKC isoforms, Gö 6976, did not affect the potentiating actions of PACAP (Fig. 7, C and D) . The substantial reduction in PACAP-mediated potentiation resulting from TPA and bisindolylmaleimide indicates that PKC activity contributes to PACAP-induced potentiation of depolarization-evoked Ca 2ϩ transients.
Finally, the potential contribution of the MAPK pathway was examined. To assess whether the MAPK pathway was activated by PACAP, cultured SCN neurons were stimulated FIG. 5. PACAP-mediated potentiation of glutamatergic neurotransmission. A: AP5 and DNQX were repeatedly applied and withdrawn to elicit glutamate-mediated Ca 2ϩ transients. During the 3 rd application of AP5 and DNQX, PACAP (1 nM) was applied for 90 s then washed from the perfusion solution. Little effect of 1 nM PACAP on the amplitude of Ca 2ϩ transients mediated by synaptically released glutamate was observed. During the 5 th application of AP5 and DNQX, PACAP (200 nM) was applied for 90 s then washed from the perfusion solution. Subsequent withdrawal of AP5 and DNQX triggered a marked potentiation of Ca 2ϩ transients. Graphical representations of mean synaptically evoked Ca 2ϩ rise. The two bars per condition represent the responses to the two consecutive evoked Ca 2ϩ transients either immediately before or immediately after PACAP administration. B: GABA A receptor modulation does not contribute to PACAP-induced potentiation of Ca 2ϩ transients. Top trace; Withdrawal of AP5 and DNQX at the beginning of the experiment triggered Ca 2ϩ transients. Administration of bicuculline (20 M) potentiated Ca 2ϩ transients initiated by withdrawal of AP5 and DNQX from the perfusion solution, indicating tonic inhibitory GABAergic input. In the presence of bicuculline, PACAP (200 nM: 90 s) potentiated Ca 2ϩ transients initiated by synaptic glutamate release. Bottom trace; A relatively quiescent cell became responsive to AP5 and DNQX withdrawal after PACAP administration. This result indicates that PACAP-mediated potentiation of glutamatergic neurotransmission is not likely to result from modulation of GABA A receptor activation. Graphical representations of mean synaptically evoked Ca 2ϩ rise. Bars represent the sequential evoked Ca 2ϩ responses either immediately before or immediately after PACAP administration. C: to verify that SCN neurons exhibit PACAP-evoked potentiation of glutamatergic neurotransmission, non-SCN neurons were irreversibly labeled with a fluorescent chloromethyl derivative tag (CellTracker). This tissue was then co-cultured with SCN tissue and the CellTracker fluorescence signal was used to distinguish the two neuronal populations. C1: CellTracker fluorescence signal from non-SCN neurons. C2: Fura-2 fluorescence signal from the same panel as above. Arrows identify SCN neurons. C3: Fura-2 traces from two SCN neurons (arrows). In both cells PACAP (200 nM) administration triggered a dramatic potentiation of Ca 2ϩ influx mediated by the synaptic release of glutamate. These data confirm that PACAP potentiates responses of neurons derived from the SCN. *: P Ͻ 0.05, 2-tailed Student's t-test. with PACAP (1 or 200 nM; 5 min) and then lysed, and cell extracts were immunoblotted for the activated (i.e., dually phosphorylated; Thr-202 and Tyr-204) forms of the extracellular signal-regulated kinases erk-1 and erk-2 (here, collectively referred to as ERK). Relative to control, mock-treated cultures, 200 nM PACAP stimulated robust ERK activation, whereas 1 nM PACAP triggered a more modest increase in ERK activity (Fig. 8A) . Pretreatment (20 min) of SCN neurons with the MEK inhibitors U0126 (10 M) or PD 98059 (50 M) blocked PACAP (200 nM)-induced activation of ERK (Fig. 8B ). Membranes were also probed with an antibody that detects total ERK. Immunocytochemistry was used to show that PACAP (200 nM) stimulates ERK activation (Fig. 8C) . The PACAP-induced ERK activity profile is similar to the profile for PACAP-induced potentiation of Ca 2ϩ transients, and thereby raises the possibility that the MAPK pathway couples PACAP to potentiation of Ca 2ϩ transients.
To assess the contribution of the MAPK pathway to PACAP-dependent facilitation of Ca 2ϩ transients, SCN cells were pretreated (20 min) and continuously perfused with MEK inhibitors. Using the same protocol as above ( Fig. 2A) , cells were repeatedly challenged with K ϩ (15 mM) before and after administration (2 min) of PACAP (200 nM; Fig. 9, A and B) . Ca 2ϩ transients; however, the ability of PACAP to potentiate these transients was blocked (Fig. 9, A and C) . As with U0126, PD 98059 (50 M) blocked PACAP-mediated potentiation of K ϩ -evoked Ca 2ϩ transients (Fig. 9, B and C) . Together these findings reveal that PACAP stimulation of the MAPK pathway is required for Ca 2ϩ transient potentiation.
D I S C U S S I O N
Within the SCN, release of glutamate from RHT nerve terminals plays a central role in light-induced entrainment of the circadian clock. The phase regulating effects of light are the likely result of glutamate-induced increases in cytosolic Ca 2ϩ within SCN neurons. Thus modulators of glutamate signaling could play an important role in regulating the phase-shifting actions of glutamate. For this study, we examined the modulatory actions of PACAP 1-38. The data presented here reveal PACAP as a potent regulator of glutamate-induced Ca 2ϩ transients. Many neurons became responsive to glutamate only after PACAP administration, suggesting that PACAP may set the lower concentration threshold required for glutamate to initiate a robust rise in postsynaptic cytosolic Ca 2ϩ . This effect of PACAP is mediated by MAPK pathway-dependent potentiation of L-type VACC activity.
Evoked Ca 2ϩ rises and PACAP
One of the well-characterized physiological effects of PACAP is mobilization of intracellular Ca 2ϩ stores. Indeed, our data reveal that PACAP elicits marked Ca 2ϩ transients in a large percentage of cells. PACAP-mediated increases in cytosolic Ca 2ϩ are triggered by activation of PLC, which in turn triggers IP3 production, thereby leading to release of Ca 2ϩ from intracellular stores (Tanaka et al. 1996 (Tanaka et al. , 1997 . This effect has been observed in a variety of cell types including neurons cultured from the SCN (Kopp et al. 1999) .
Although Ca 2ϩ mobilization is of significant interest, our focus was on the ability of PACAP to modulate depolarizing Ca 2ϩ responses. Toward this end, neurons were repeatedly stimulated with glutamate or depolarizing levels of potassium, thus creating a baseline response profile to which we could compare glutamate-evoked responses after PACAP adminis- tration. With this paradigm, we found that PACAP triggered a marked potentiation of evoked Ca 2ϩ transients. In fact, in some neurons, responsiveness was established only after pretreatment with PACAP. Maintaining TTX in the perfusion buffers throughout the experimental period obviated the complicating influence of action potential mediated transmitter release. Thus the observed actions of PACAP were the result of postsynaptic modulation of evoked Ca 2ϩ transients.
Rapid, glutamate-evoked, cytosolic Ca 2ϩ transients are initiated by the opening of ionotropic glutamate receptor channels, and secondarily, by depolarization-mediated activation of VACCs. To determine whether PACAP was functioning as a modulator of glutamate-or VACC-mediated responses, the modulatory actions of PACAP on K ϩ -evoked Ca 2ϩ transients were tested. Depolarization-mediated activation of VACC was potentiated by PACAP. Nimodipine, an L-type Ca 2ϩ channel inhibitor, blocked PACAP-mediated potentiation of glutamateevoked as well as depolarization-evoked Ca 2ϩ transients, in-dicating that PACAP was facilitating Ca 2ϩ influx by potentiating the actions of L-type VACCs. PACAP-mediated potentiation of Ca 2ϩ influx may result from the modulation of L-type VACC conductance properties. Conversely, PACAP may regulate cellular excitability by closing K ϩ channels, thereby triggering membrane depolarization. Data from a number of studies support both mechanisms of action (Bruch et al. 1997; Chatterjee et al. 1996; Chik et al. 1996; Darvish and Russell 1998; Ichinose et al. 1998; Tanaka et al. 1996, 19971997) . Thus, in addition to potentiating responses to glutamate, PACAP may function as a broad-spectrum modulator of transmitters that trigger membrane depolarization.
PACAP potentiated the evoked responses of a subpopulation (55%) of SCN neurons. It is unclear why potentiation was not observed in all cells tested. One possible explanation is that the effects of PACAP are phase-dependent. In dispersed culture, SCN neurons are rhythmic, but asynchronous (Welsh et al. 1995) , and thus it is conceivable that only a subset of cells are ever in the correct phase to elicit a modulatory response by PACAP. Another possible explanation is that only certain subsets of SCN cells contain the intracellular machinery required for PACAP to potentiate evoked Ca 2ϩ responses. 
Potentiation of synaptic transmission
PACAP-induced potentiation of Ca 2ϩ transients was also observed under conditions of synaptic glutamate release. In this approach SCN neurons were cultured with glutamatergic neurons from the surrounding hypothalamic area. A rise in neuronal Ca 2ϩ levels was initiated by removing ionotropic glutamate receptor antagonists from the perfusion media. This Ca 2ϩ rise was blocked by TTX, indicating its action potentialdependent origin. Whole cell patch-clamp recording has also been used to examine membrane depolarization and an increase in spontaneous excitatory postsynaptic potentials mediated by the withdrawal of glutamate receptor antagonist . With this assay, we observed that bath application of PACAP triggered a robust potentiation of glutamate-mediated Ca 2ϩ transients. Additionally, some cells became responsive to tonic glutamate release only on PACAP receptor stimulation. These effects were purely modulatory in nature since Ca 2ϩ returned to basal levels after reintroduction of glutamate receptor antagonists. Given that the modulatory actions elicited by PACAP were similar regardless of whether glutamate was exogenously applied or synaptically released, it is likely that the effects of PACAP were via a postsynaptic site of action, although a presynaptic modulatory action of PACAP cannot be ruled out.
To validate that SCN neurons exhibit PACAP-evoked potentiation of glutamatergic neurotransmission, co-cultured cells from surrounding hypothalamic region were irreversibly labeled with a fluorescent tag. The fluorescent tag was then used to identify the two populations of neurons. This approach allowed us to specifically record from SCN neurons, and thereby confirm that PACAP potentiates the effects of synaptically released glutamate in cells derived from the SCN. However, since the majority of endogenous activity assays did not use this technique to discriminate between the two populations, we cannot exclude the possibility that we also recorded from some non-SCN cells.
Several studies have shown that PACAP exerts modulatory actions via both presynaptic and postsynaptic mechanisms. Along these lines, PACAP increases the frequency of postsynaptic potentials in the hippocampus (a presynaptic effect; Roberto and Brunelli 2000) , whereas in supraoptic neurons, PACAP has little effect on the frequency of spontaneous postsynaptic currents, but rather, triggers membrane depolarization via a postsynaptic mechanism and thereby increases the neuronal firing rate (Shibuya et al. 2000) . It is important to note that the blockade of GABA A receptor activity with bicuculline did not alter the ability of PACAP to modulate Ca 2ϩ transients elicited by synaptic glutamate release, indicating that PACAP does not facilitate glutamate signaling by modulating the inhibitory actions of GABA at the GABA A receptor.
Second messenger pathways
PACAP triggers a wide array of molecular physiological responses (reviewed by Vaudry et al. 2000) . This diversity of actions may be in part the result of PACAP's ability to activate a variety of signaling pathways. One goal of this investigation was to identify the second messenger signaling pathways that couple PACAP to potentiation of glutamate-induced Ca 2ϩ transients. Although PACAP triggered Ca 2ϩ transients in a subpopulation of neurons, this physiological response was not required for PACAP to potentiate evoked Ca 2ϩ transients, suggesting that Ca 2ϩ -inducible second messenger signaling pathways, such as CaMKs, are not involved in PACAP-mediated potentiation of transients. Increased cAMP is also not likely to be directly involved, given that forskolin-mediated elevation in cAMP did not potentiate evoked Ca 2ϩ transients. Furthermore, inhibition of PKA with Rp-cAMPs did not affect the potentiating actions of PACAP. Previous work using a similar model system revealed that alterations in cAMP (either increased or decreased) tended to reduce rather than potentiate the amplitude of evoked Ca 2ϩ responses (Obrietan and van den Pol 1997) . Considering these results, we focused on the potential role of the MAPK pathway.
Pretreatment with the MEK inhibitors U0126 or PD 98059 blocked PACAP-induced potentiation of Ca 2ϩ transients initiated by exogenous application of K ϩ . Inhibitor results were complemented by Western and immunocytochemical data, showing that PACAP triggers ERK phospho-activation. Similar results for PACAP-induced ERK activation have been observed in cerebellar granule cells (Villalba et al. 1997) .
Although the mechanism by which MAPK signaling potentiates L-type Ca 2ϩ channels is not known, there are several potential routes. The most direct model would involve ERK or one of the downstream ERK activated kinases phosphorylating the L-type channel. The phosphorylation could potentiate Ltype Ca 2ϩ currents by triggering a shift in the voltage-dependence of channel activation. Indeed, several studies have shown that the L-type channel conductance properties can be regulated in a phosphorylation-dependent manner (reviewed by Catterall 2000). Interestingly, work in cardiomyocytes has shown that leukemia inhibitory factor (LIF) enhances L-type Ca 2ϩ currents through a mechanism that requires the MAPK pathway; PD 98059 completely inhibited the LIF-induced increase in L-type Ca 2ϩ currents (Murata et al. 1999 ). Additionally, signaling via the MAPK pathway has been shown to trigger activation of the L-type Ca 2ϩ channel in neuroblast cells (Ekinci et al. 1999 ). These observations, coupled with our data, raise the possibility that the MAPK pathway plays a general role as a modulator of cellular excitability.
The potential role of PKC as a signaling intermediate coupling PACAP to potentiation of depolarization-induced Ca 2ϩ influx was also examined. Toward this end, a combination of PKC inhibitors and long-term TPA treatment (to down-regulate PKC expression) was employed. Both PKC down-regulation and pretreatment with bisindolylmaleimide attenuated the potentiating actions of PACAP. Importantly, significant residual modulatory activity persisted after disruption of PKC signaling. These data suggest that PKC activity contributes to, but is not essential for, PACAP-mediated potentiation of depolarization-induced Ca 2ϩ transient. It is interesting to note that in some model systems, PKC can trigger MAPK pathway activation (Corbit et al. 2000; Troller et al. 2001) . Additional studies will be required to identify the exact mechanism by which PKC contributes to this process.
MAPK, PACAP, and the circadian clock
The results presented here reveal a new role for the MAPK pathway in the SCN as a modulator of glutamatergic neurotransmission. Within the past several years, a number of reports have begun to examine the role of signaling via the MAPK pathway in the circadian clock. These studies have revealed that photic input during the subjective night, but not during the subjective day, triggers a marked increase in MAPK activation in the SCN (Obrietan et al. 1998) , and that the MAPK pathway couples glutamate-receptor activation to gene expression in SCN neurons (Obrietan et al. 1999) . A role for the MAPK pathway in endogenous circadian timing has been identified in immortalized cells, where TPA-induced circadian oscillations in gene expression are inhibited by blocking the MAPK pathway (Akashi and Nishida 2000) . In addition, MAPK pathway activation is rhythmically regulated in the avian pineal gland (Sanada et al. 2000) . Likewise, the activation state of the MAPK pathway is regulated in a circadian-dependent manner in mouse SCN (Obrietan et al. 1998 ). This observation, coupled with the data presented here, raises the possibility that rhythmic regulation of neuronal excitability in the SCN may be downstream of circadian variations in MAPK pathway activity. In support of this hypothesis, a recent report revealed that rhythmically regulated signaling via the MAPK pathway augments cGMP-gated cationic conductance in chick retinal cones in a phase-dependent manner (Ko et al. 2001) .
PACAP has pleotropic effects on the circadian timing system. For example, during the subjective day, PACAP administration to the SCN triggers robust phase shifts in rhythmic electrical activity (Hannibal et al. 1997) . Given that glutamate is not a regulator of the circadian clock during the subjective day, this observation raises the possibility that PACAP is a direct modulator of clock timing, possibly by triggering PKAdependent gene expression. Conversely, during the subjective night, PACAP has been shown to function as a complex modulator of glutamate-dependent phase shifting. Along these lines, PACAP attenuates glutamate-induced phase shifts during the early subjective night and potentiates glutamate-induced phase advances during the late subjective night (Chen et al. 1999 ). In addition, relatively low concentrations of PACAP (10 pM) potentiate NMDA channel conductance, whereas at higher doses (Ͼ10 nM), PACAP causes NMDA receptor inhibition in SCN neurons (Harrington et al. 1999 ). PACAP has also been reported to modulate glutamate signaling in an NMDA receptor-independent manner (Kopp et al. 2001) . The modulatory actions of PACAP described here appear to be distinct from these observations, given the targets of PACAP induced potentiation and the mechanism of PACAP-mediated potentiation. In conclusion, the results presented here identify new modulatory roles for PACAP and the MAPK pathway in the SCN.
